AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GALECTIN THERAPEUTICS INC Director's Dealing 2017

Dec 18, 2017

Director's Dealing

Opens in your device viewer

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2017-12-14

Reporting Person: FREEMAN KEVIN D (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-14	Stock option (right to buy)	$2.39	A	46875	Acquired	2027-12-14	Common stock (46875)	Direct

F1: The options vest 100% on December 14, 2018.